• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-106a通过靶向磷酸酶和张力蛋白同源物促进非小细胞肺癌的生长和转移。

miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.

作者信息

Xie Xiao, Liu Hong-Tao, Mei Ju, Ding Fang-Bao, Xiao Hai-Bo, Hu Feng-Qing, Hu Rui, Wang Ming-Song

机构信息

Department of Cardio-Thoracic Surgery, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine Shanghai 200092, P. R. China.

Department of Cardio-Thoracic Surgery, The first Affiliated Hospital of Soochow University Suzhou 215006, P. R. China.

出版信息

Int J Clin Exp Pathol. 2015 Apr 1;8(4):3827-34. eCollection 2015.

PMID:26097565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4466952/
Abstract

MicroRNAs are a class of small non-coding RNAs that play essential roles in cancer development and progression. Recent studies suggested that abnormal expression of miRNAs occurs frequently in non-small cell lung cancer (NSCLC) tissues compared to adjacent normal tissues. In this study, we investigated the expression and the biological roles of miR-106a in non-small cell lung cancer. Our results showed that miR-106a was up-regulated in NSCLC tissues and cell lines. Inhibition of miR-106a in NSCLC cells substantially inhibited cell proliferation, migration, and invasion. Phosphatase and tensin homolog (PTEN) was identified as a direct target of miR-106a, and over-expression of miR-106a suppressed PTEN by direct binding to its 3'-untranslated region (3'-UTR). Furthermore, the presence of miR-106a was inversely correlated with PTEN in NSCLC tissues. Overall, this study suggested that miR-106a inhibited the growth and metastasis of NSCLC cells by decreasing PTEN expression. These data provide novel insights with potential therapeutic applications for the treatment of NSCLC.

摘要

微小RNA是一类小的非编码RNA,在癌症的发生和发展中起着至关重要的作用。最近的研究表明,与相邻正常组织相比,微小RNA在非小细胞肺癌(NSCLC)组织中经常出现异常表达。在本研究中,我们调查了miR-106a在非小细胞肺癌中的表达及其生物学作用。我们的结果表明,miR-106a在NSCLC组织和细胞系中上调。抑制NSCLC细胞中的miR-106a可显著抑制细胞增殖、迁移和侵袭。磷酸酶和张力蛋白同源物(PTEN)被确定为miR-106a的直接靶点,miR-106a的过表达通过直接结合其3'非翻译区(3'-UTR)抑制PTEN。此外,在NSCLC组织中,miR-106a的存在与PTEN呈负相关。总体而言,本研究表明miR-106a通过降低PTEN表达来抑制NSCLC细胞的生长和转移。这些数据为NSCLC的治疗提供了具有潜在治疗应用的新见解。

相似文献

1
miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.微小RNA-106a通过靶向磷酸酶和张力蛋白同源物促进非小细胞肺癌的生长和转移。
Int J Clin Exp Pathol. 2015 Apr 1;8(4):3827-34. eCollection 2015.
2
MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.微小 RNA-92a 通过激活 PTEN/PI3K/AKT 信号通路促进非小细胞肺癌转移中的上皮-间充质转化。
Int J Oncol. 2017 Jul;51(1):235-244. doi: 10.3892/ijo.2017.3999. Epub 2017 May 16.
3
MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).微小 RNA-21(miR-21)抑制肿瘤抑制因子 PTEN,促进非小细胞肺癌(NSCLC)的生长和侵袭。
Clin Chim Acta. 2010 Jun 3;411(11-12):846-52. doi: 10.1016/j.cca.2010.02.074. Epub 2010 Mar 16.
4
miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.miR-205 通过靶向 PTEN 促进 NSCLC 细胞的生长、转移和化疗耐药性。
Oncol Rep. 2013 Dec;30(6):2897-902. doi: 10.3892/or.2013.2755. Epub 2013 Sep 30.
5
MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.微小RNA-92a通过靶向PTEN促进非小细胞肺癌细胞的生长、转移和化疗耐药性。
Tumour Biol. 2016 Mar;37(3):3215-25. doi: 10.1007/s13277-015-4150-3. Epub 2015 Oct 2.
6
miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression.miR-17 抑制剂通过增加 PTEN 表达抑制骨肉瘤肿瘤生长和转移。
Biochem Biophys Res Commun. 2014 Feb 7;444(2):230-4. doi: 10.1016/j.bbrc.2014.01.061. Epub 2014 Jan 22.
7
Upregulation of Long Noncoding RNA GAS5 Inhibits Lung Cancer Cell Proliferation and Metastasis via miR-205/PTEN Axis.长链非编码 RNA GAS5 的上调通过 miR-205/PTEN 轴抑制肺癌细胞增殖和转移。
Med Sci Monit. 2019 Mar 30;25:2311-2319. doi: 10.12659/MSM.912581.
8
MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN.微小 RNA-21(miR-21)通过靶向 PTEN 促进非小细胞肺癌细胞的生长、转移以及化疗或放疗耐药性。
Mol Cell Biochem. 2013 Jan;372(1-2):35-45. doi: 10.1007/s11010-012-1443-3. Epub 2012 Sep 6.
9
MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.微小RNA-139-5p通过靶向胰岛素样生长因子1受体抑制人非小细胞肺癌的细胞增殖和侵袭。
Int J Clin Exp Pathol. 2015 Apr 1;8(4):3864-70. eCollection 2015.
10
miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.微小RNA-99a通过靶向AKT1信号通路抑制人非小细胞肺癌细胞的转移。
J Cell Biochem. 2015 Feb;116(2):268-76. doi: 10.1002/jcb.24965.

引用本文的文献

1
A new era of cancer immunotherapy: vaccines and miRNAs.癌症免疫疗法的新时代:疫苗与微小RNA
Cancer Immunol Immunother. 2025 Apr 1;74(5):163. doi: 10.1007/s00262-025-04011-5.
2
MicroRNA155 in non-small cell lung cancer: a potential therapeutic target.非小细胞肺癌中的微小RNA155:一个潜在的治疗靶点。
Front Oncol. 2025 Feb 3;15:1517995. doi: 10.3389/fonc.2025.1517995. eCollection 2025.
3
Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review.不同类型肺癌中微小RNA高效性的最新进展:综述
Cancer Cell Int. 2023 Nov 20;23(1):284. doi: 10.1186/s12935-023-03133-z.
4
Overview of miR-106a Regulatory Roles: from Cancer to Aging.miR-106a调控作用概述:从癌症到衰老
Bioengineering (Basel). 2023 Jul 27;10(8):892. doi: 10.3390/bioengineering10080892.
5
miRNAs Participate in the Regulation of Oxidative Stress-Related Gene Expression in Endometrioid Endometrial Cancer.miRNAs 参与调控子宫内膜样型子宫内膜癌中氧化应激相关基因的表达。
Int J Mol Sci. 2022 Dec 13;23(24):15817. doi: 10.3390/ijms232415817.
6
Identification of common microRNA between COPD and non-small cell lung cancer through pathway enrichment analysis.通过通路富集分析鉴定 COPD 和非小细胞肺癌之间的常见 microRNA。
BMC Genom Data. 2021 Oct 12;22(1):41. doi: 10.1186/s12863-021-00986-z.
7
Long non‑coding RNA HAND2‑AS1/miR‑106a/PTEN axis re‑sensitizes cisplatin‑resistant ovarian cells to cisplatin treatment.长链非编码 RNA HAND2-AS1/miR-106a/PTEN 轴使顺铂耐药的卵巢细胞重新对顺铂治疗敏感。
Mol Med Rep. 2021 Nov;24(5). doi: 10.3892/mmr.2021.12402. Epub 2021 Sep 3.
8
Horizontal Transfer of miR-643 from Cisplatin-Resistant Cells Confers Chemoresistance to Recipient Drug-Sensitive Cells by Targeting APOL6.顺铂耐药细胞来源的 miR-643 通过靶向 APOL6 水平转移赋予受体药物敏感细胞耐药性
Cells. 2021 May 28;10(6):1341. doi: 10.3390/cells10061341.
9
LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.长链非编码 RNA SGMS1-AS1 通过 miR-106a-5p/MYLI9 轴调控肺腺癌细胞增殖、迁移、侵袭和 EMT 进程。
Thorac Cancer. 2021 Jul;12(14):2104-2112. doi: 10.1111/1759-7714.14043. Epub 2021 Jun 1.
10
Small in Size, but Large in Action: microRNAs as Potential Modulators of PTEN in Breast and Lung Cancers.体积虽小,作用巨大:微小 RNA 作为乳腺癌和肺癌中 PTEN 的潜在调节剂。
Biomolecules. 2021 Feb 18;11(2):304. doi: 10.3390/biom11020304.

本文引用的文献

1
An integrative analysis of PIK3CA mutation, PTEN, and INPP4B expression in terms of trastuzumab efficacy in HER2-positive breast cancer.关于HER2阳性乳腺癌中PIK3CA突变、PTEN和INPP4B表达对曲妥珠单抗疗效的综合分析。
PLoS One. 2014 Dec 26;9(12):e116054. doi: 10.1371/journal.pone.0116054. eCollection 2014.
2
MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2.微小RNA-152通过抑制成纤维细胞生长因子2来抑制非小细胞肺癌细胞的增殖和侵袭。
Exp Mol Med. 2014 Sep 5;46(9):e112. doi: 10.1038/emm.2014.51.
3
miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25.微小RNA-200c通过直接靶向泛素特异性肽酶25抑制人非小细胞肺癌的侵袭和转移。
Mol Cancer. 2014 Jul 6;13:166. doi: 10.1186/1476-4598-13-166.
4
MiR-195 targets HDGF to inhibit proliferation and invasion of NSCLC cells.微小RNA-195靶向肝癌衍生生长因子以抑制非小细胞肺癌细胞的增殖和侵袭。
Tumour Biol. 2014 Sep;35(9):8861-6. doi: 10.1007/s13277-014-2153-0. Epub 2014 Jun 3.
5
MiR-132 suppresses the migration and invasion of lung cancer cells via targeting the EMT regulator ZEB2.微小RNA-132通过靶向上皮-间质转化调节因子锌指蛋白E盒结合因子2抑制肺癌细胞的迁移和侵袭。
PLoS One. 2014 Mar 13;9(3):e91827. doi: 10.1371/journal.pone.0091827. eCollection 2014.
6
Alterations of INPP4B, PIK3CA and pAkt of the PI3K pathway are associated with squamous cell carcinoma of the lung.PI3K信号通路中INPP4B、PIK3CA和磷酸化Akt的改变与肺鳞状细胞癌相关。
Cancer Med. 2014 Apr;3(2):337-48. doi: 10.1002/cam4.191. Epub 2014 Feb 5.
7
Upregulated miR-106a plays an oncogenic role in pancreatic cancer.上调的 miR-106a 在胰腺癌中发挥致癌作用。
FEBS Lett. 2014 Mar 3;588(5):705-12. doi: 10.1016/j.febslet.2014.01.007. Epub 2014 Jan 18.
8
Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer.微小 RNA-124 通过靶向 Flotillin-1 调节乳腺癌的增殖和迁移。
Mol Cancer. 2013 Dec 13;12:163. doi: 10.1186/1476-4598-12-163.
9
Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM.miR-106a表达降低通过靶向胶质母细胞瘤中的SLC2A3抑制胶质瘤细胞葡萄糖摄取和增殖。
BMC Cancer. 2013 Oct 14;13:478. doi: 10.1186/1471-2407-13-478.
10
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.